Literature DB >> 26079028

[Adjuvant IMRT in endometrial carcinoma: the French RTCMIENDOMETRE-study].

Robert Förster, Katja Lindel.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26079028     DOI: 10.1007/s00066-015-0828-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

1.  Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer.

Authors:  Yukiharu Todo; Hidemichi Watari; Sokbom Kang; Noriaki Sakuragi
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

2.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.

Authors:  Yukiharu Todo; Hidenori Kato; Masanori Kaneuchi; Hidemichi Watari; Mahito Takeda; Noriaki Sakuragi
Journal:  Lancet       Date:  2010-02-24       Impact factor: 79.321

3.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Authors:  R A Nout; V T H B M Smit; H Putter; I M Jürgenliemk-Schulz; J J Jobsen; L C H W Lutgens; E M van der Steen-Banasik; J W M Mens; A Slot; M C Stenfert Kroese; B N F M van Bunningen; A C Ansink; W L J van Putten; C L Creutzberg
Journal:  Lancet       Date:  2010-03-06       Impact factor: 79.321

4.  A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418.

Authors:  Anuja Jhingran; Kathryn Winter; Lorraine Portelance; Brigitte Miller; Mohammad Salehpour; Rakesh Gaur; Luis Souhami; William Small; Lawrence Berk; David Gaffney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-28       Impact factor: 7.038

5.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 6.  Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Authors:  Giorgio Bogani; Sean C Dowdy; William A Cliby; Fabio Ghezzi; Diego Rossetti; Andrea Mariani
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

7.  The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline.

Authors:  Ann Klopp; Benjamin D Smith; Kaled Alektiar; Alvin Cabrera; Antonio L Damato; Beth Erickson; Gini Fleming; David Gaffney; Kathryn Greven; Karen Lu; David Miller; David Moore; Daniel Petereit; Tracey Schefter; William Small; Catheryn Yashar; Akila N Viswanathan
Journal:  Pract Radiat Oncol       Date:  2014-03-31

8.  Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma.

Authors:  Günter Emons; Rainer Kimmig
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-11       Impact factor: 4.553

9.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

  9 in total
  1 in total

Review 1.  Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experience.

Authors:  Iris Mueller; Gerhard Kametriser; Volker R Jacobs; Gerhard Bogner; Alfons Staudach; Horst Koch; Pia Wolfrum-Ristau; Christiane Schausberger; Thorsten Fischer; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2016-06-27       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.